跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NORMONLAX POLVO PARA SOLUCION ORAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
NORMONLAX POLVO PARA SOLUCION ORAL
Approved
STANDARD
NORMONLAX POLVO PARA SOLUCION ORAL
Laboratorios Normon S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 23, 2021
Approval ID
6ea6fede6bbcc787
Company
Laboratorios Normon S.A.
Type
Standard
Approval Details
Approval Id
6ea6fede6bbcc787
Drug Cima Aemps Name
NORMONLAX POLVO PARA SOLUCION ORAL
Register Number
86177
Holder Company Name
Laboratorios Normon S.A.
Marketing Company Name
Laboratorios Normon S.A.
Authorization Date
2021-08-23
Dosage Form
POLVO PARA SOLUCIÓN ORAL
Dose
13,1 g / 0,35 g / 0,17 g / 0,04 g
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Normon S.A.
Active Ingredients
MACROGOL 3350
13,125 g
SODIO BICARBONATO
0,1785 g
SODIO CLORURO
0,3507 g
CLORURO DE POTASIO
0,0466 g
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 23, 2021
Approval ID
6ea6fede6bbcc787
Type
Standard
Back to CIMA-AEMPS Approvals